Author:
Satpathy Raghunath,Acharya Sonali
Reference78 articles.
1. Abidi, S. H., Almansour, N. M., Amerzhanov, D., Allemailem, K. S., Rafaqat, W., Ibrahim, M. A. A., la Fleur, P., Lukac, M., & Ali, S. (2021). Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase. Scientific Reports, 11(1), 10290. doi:10.1038/s41598-021-89724-0
2. Aljabali, A. A., Tambuwala, M. M., Barh, D., & Lundstrom, K. (2022). Therapeutic Challenges in COVID. In COVID-19: From Bench to Bedside (pp. 1-9). Boca Raton; CRC Press.
3. Aljehany, B. M., & Allily, R. K. (2022). Impact of Covid-19 Quarantine on Life Style Changes, In the Western Saudi Arabia: A Cross-Sectional Study. Journal of Organizational Behavior Research, 7(1), 182-197.
4. Andrei, C. S. E. P., Vaida, L., Bungau, S., & Todor, B. I. (2015). Clinical and Biological Correlations in Toxoplasma gondii Infection in HIV Immune Suppressed Persons. Iranian Journal of Public Health, 44(7), 1012.
5. Appelberg, S., Gupta, S., Svensson Akusjärvi, S., Ambikan, A. T., Mikaeloff, F., Saccon, E., Végvári, Á, Benfeitas, R., Sperk, M., Ståhlberg, M., et al. (2020). Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerging Microbes and Infections, 9(1), 1748-1760. doi:10.1080/22221751.2020.1799723